Desjardins Reiterates C$34.50 Price Target for Extendicare (TSE:EXE)

Extendicare (TSE:EXE) has been assigned a C$34.50 price objective by equities researchers at Desjardins in a research report issued on Wednesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Desjardins’ price objective would suggest a potential upside of 21.52% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. Canadian Imperial Bank of Commerce boosted their price objective on Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. National Bank Financial boosted their target price on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. BMO Capital Markets upped their price objective on Extendicare from C$24.00 to C$30.00 in a research report on Monday, March 2nd. Finally, TD Securities raised Extendicare from a “hold” rating to a “buy” rating and upped their target price for the company from C$19.00 to C$32.00 in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of C$29.38.

Extendicare Price Performance

Shares of TSE EXE traded up C$0.41 during midday trading on Wednesday, hitting C$28.39. The stock had a trading volume of 119,232 shares, compared to its average volume of 315,386. The company has a market capitalization of C$2.68 billion, a PE ratio of 25.51 and a beta of 1.18. The stock has a 50 day simple moving average of C$26.63 and a 200-day simple moving average of C$22.36. Extendicare has a 1 year low of C$12.12 and a 1 year high of C$29.99. The company has a quick ratio of 0.98, a current ratio of 1.37 and a debt-to-equity ratio of 91.85.

Extendicare (TSE:EXE) last released its earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share for the quarter. The business had revenue of C$462.03 million for the quarter. Extendicare had a return on equity of 47.65% and a net margin of 5.82%. On average, sell-side analysts expect that Extendicare will post 0.6134729 EPS for the current fiscal year.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.